Group 1 - The core point of the article is that the company, Giant Bio, has been actively repurchasing its shares, with a total of 520,000 shares repurchased this year, amounting to 183 million HKD [2][3] - On December 30, the company repurchased 400,000 shares at a price range of 33.480 to 33.760 HKD, totaling 13.44 million HKD, while the stock closed at 33.540 HKD, down 2.95% for the day [2] - Since December 29, the company has conducted share buybacks for two consecutive days, repurchasing a total of 800,000 shares with a cumulative amount of 27.26 million HKD, during which the stock price has decreased by 5.89% [2] Group 2 - The detailed buyback history shows that the company has consistently repurchased 40,000 shares on multiple occasions, with the highest buyback price reaching 36.480 HKD and the lowest at 34.280 HKD during the recent transactions [3] - The total buyback amount for the recent transactions includes 1.38 million HKD on December 29 and 1.44 million HKD on December 23, indicating a strategic approach to managing share price [3] - The cumulative buyback amount for the year reflects the company's commitment to supporting its stock price amidst market fluctuations [3]
巨子生物(02367.HK)12月30日回购1344.08万港元，年内累计回购1.83亿港元